Fatty acid synthase inhibitors

A compound according to Formula (I):

• wherein:
• R represents OH, or NHSO2R2;
• A represents NH or O;
• B represents O, or NR1;
• R1 represents Ar′alkyl, or AlkylCO;
• Ar and Ar′represent, independently, phenyl, thiophenyl, pyridinyl, or pyrimidinyl, all of which could be substituted with a substituting selected from the group consisting of:
• halo, including fluoro, bromo, chloro, iodo, NO2, CN, CO2R3, OR3, NR3R4, C1-10alkyl, C1-10alkoxy, aryloxy, arylalkoxy, and heteroaryloxy;
• R2 represents alkyl, Ar′alkyl, or Ar′;
• and
• R3 and R4 represent, independently, hydrogen, or C1-10alkyl;
• or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable salt complex thereof.